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bjectives We sought to determine the potential of remote ischemic periconditioning (RIPC), and
ts combination with morphine, to reduce reperfusion injury in primary percutaneous coronary
nterventions.
ackground Remote ischemic post-conditioning is implemented by applying cycles of ischemia and
eperfusion on a remote organ, which result in release of circulating factors inducing the effects of
ost-conditioning on the myocardium.
ethods A total of 96 patients (59 men) were enrolled. The patients were randomized to groups as
ollows: 33 to each treatment group (Group A: RIPC; Group B: RIPC and morphine) and 30 to the
ontrol group (Group C). Measures of efﬁcacy were achievement of full ST-segment resolution (pri-
ary), and reduction of ST-segment deviation score and peak troponin I during hospitalization.
esults A higher proportion of patients in Groups A (73%) and B (82%) achieved full ST-segment reso-
ution after percutaneous coronary intervention, compared with control patients (53%) (p  0.045). Peak
roponin I was lowest in Group B, 103.3  13.3 ng/ml, in comparison to peak levels in Group A, 166.0 
8.0 ng/ml, and the control group, 255.5  35.5 ng/ml (p  0.0006). ST-segment deviation resolution
as 87.3  2.7% in Group B, compared with 69.9  5.1% in Group A and 53.2  6.4% in the control
roup (p  0.00002). In paired comparisons between groups, Group B did better than the control group
n terms of both ST-segment reduction (p  0.0001) and peak troponin I (p  0.004), whereas Group A
ifferences from the control group did not achieve statistical signiﬁcance (p  0.054 and p  0.062,
espectively).
onclusions These ﬁndings demonstrate a cardioprotective effect of RIPC and morphine during
rimary percutaneous coronary intervention for the prevention of reperfusion injury. This is in
greement with observations that the beneﬁcial effect of RIPC is inhibited by the opioid receptor
locker naloxone. (J Am Coll Cardiol Intv 2010;3:49–55) © 2010 by the American College of
ardiology Foundation
rom the *Cardiology Department, “A. Fleming” General Hospital, Melissia, Greece; and the †Cardiology Department and
ardiac Catheterization Laboratory, Athens General Hospital “G. Gennimatas,” Athens, Greece.anuscript received August 5, 2009; revised manuscript received September 28, 2009, accepted October 15, 2009.
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50he strategy of urgent reperfusion of ischemic myocar-
ium in patients with acute ST-segment elevation myo-
ardial infarction (STEMI) has led to a significant
mprovement of outcomes, because early reperfusion
inimizes the extent of damage of heart muscle and,
deally, preserves the function of the heart. However,
eperfusion after a prolonged period of ischemia damages
he myocardium, through a process known as ischemia-
eperfusion injury (1). Post-conditioning is defined as
epetitive cycles of briefly interrupted reperfusion applied
t the onset of establishing reflow and has been shown to
ignificantly improve outcome following an episode of
See page 56
schemia and to reduce the size of myocardial infarct, when
pplied at the time of reperfusion (2,3). Ischemic post-
onditioning has also been associated with long-term im-
rovement of left ventricular function after STEMI (4).
emote ischemic post-conditioning may be achieved by
applying cycles of ischemia and
reperfusion not in the heart, but
rather in a remote organ, which
results in release of circulating
factors inducing the effects of
post-conditioning on the myo-
cardium (5).
A growing body of evidence
suggests that mitochondrial per-
meability transition pores (mPTP)
may play a major part in post-
conditioning, on the basis of
such observations as mPTP open-
ing during early reperfusion and
odification of reperfusion phenomena by genetic alter-
tions of mPTP (6). Inhibition of mPTP opening has been
eported to be an important mechanism underlying the
rotective effect of post-conditioning (7), and the signaling
athway initiated by opioid receptor activation has been
hown to lead to this cardioprotective effect, by targeting
itochondria (8). In a similar manner, Piot et al. (9) showed
hat the immunosuppressant drug cyclosporine, a potent
PTP-opening inhibitor, administered shortly before pri-
ary reperfusion in patients with STEMI, was associated
ith smaller infarct size.
The aim of the present study was to assess the potentially
dditive effect of remote ischemic periconditioning (RIPC)
nd opioid receptor activation, by morphine administration,
oth applied at the onset of reperfusion, on specific myo-
ardial damage indicators. (We use “periconditioning” in-
tead of “post-conditioning” to indicate that ischemic con-
itioning was applied while ischemia persisted—a few
bbreviations
nd Acronyms
PTP  mitochondrial
ermeability transition pores
CI  percutaneous
oronary intervention
IPC  remote ischemic
ericonditioning
TEMI  ST-segment
levation myocardial
nfarction
nI  troponin Iinutes before balloon inflation—and during the time ofeperfusion.) The clinical context of the study was primary
ercutaneous coronary intervention (PCI) in patients with
cute STEMI.
ethods
opulation and treatment assignment. Ninety-six patients
ere enrolled and were submitted to primary PCI. Inclusion
riteria were: 1) acute STEMI (ST-segment elevation 1
m, in more than 2 contiguous leads, with accompanying
hest pain); 2) symptom onset not more than 6 h before
resentation; and 3) age 35 to 75 years. Patients in Killip
lass VI or with moderate/severe renal failure (serum creat-
nine higher than 1.5 mg/dl) were excluded. Patients pro-
ided informed consent. The study protocol was approved
y the Institutional Review Board.
The patients were randomly assigned to 3 groups: Group
was submitted to RIPC, Group B received both RIPC
nd intravenous morphine infusion at the onset of reperfu-
ion, and Group C was control patients (no RIPC was
pplied and no morphine was used at the onset of reperfu-
ion). All patients received standard pharmacological treat-
ent as per the institutional guidelines for STEMI.
oronary angiography and PCI. All patients underwent cor-
nary angiography by the Judkins technique, and PCI was
erformed at the presumed culprit lesion. The choice of
uidewires, balloons, stent types (bare-metal or drug-
luting), and stent characteristics was made by each indi-
idual operator according to common laboratory practice.
esions were crossed with a guidewire and pre-dilated, with
nflation of a balloon to its nominal pressure, corresponding
o the diameter of the vessel. Additional inflations were
Figure 1. Study Plan
Plan of remote ischemic periconditioning application and administration of
morphine in patients submitted to primary coronary intervention, accord-
ing to the randomization group. The 0 point in the time axis represents the
estimated time of ﬁrst balloon inﬂation. IV  intravenous.
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51mployed if necessary. Stents were then deployed according
o established techniques.
IPC and morphine infusion. We induced RIPC by inflating
blood pressure cuff placed on the upper limb to 20 mm Hg
bove systolic arterial pressure for 4 min and deflating the
uff for 4 min; 3 such cycles were performed, beginning 10
in before the estimated time of first balloon inflation. (It
s evident that the exact time of first balloon inflation could
ot be pinpointed beforehand, nor would it be ethical to
elay balloon inflation in order to keep an exact period of
ime from the beginning of RIPC; as a consequence, RIPC
egan approximately 10 min before the first balloon infla-
ion). Patients belonging in Group C (control) also had a
anometer cuff placed on their upper arm, which was
nflated up to a pressure level of 20 mm Hg below their
iastolic blood pressure.
Morphine was administered as an intravenous slow infu-
ion of 5 mg of morphine sulfate, beginning 5 min before
he estimated time of first balloon inflation. Control pa-
ients received a similar infusion of normal saline solution,
ithout addition of morphine. Figure 1 illustrates a diagram
f the treatment plan per randomization group.
Table 1. Baseline Epidemiological and Clinical Features of the Study Popul
Group
(n  33
Demographic and clinical parameters
Age, yrs 62.9 1
Men 20 (61%
Smoking 24 (73%
Dyslipidemia 16 (48%
Diabetes 10 (30%
Hypertension 16 (48%
Serum creatinine, mg/dl 1.1 0
Previous MI 5 (15%
History of previous PCI 4 (12%
CAD history 10 (30%
Ejection fraction 0.45 0
Treatment*
Beta-blocker 32 (99%
CCB 5 (15%
ACEI 28 (85%
ARB 1 (3%)
Statin 33 (100%
ST-segment deviation score, mm 18.6 9
PCI-related parameters
Time from onset of pain to ﬁrst balloon inﬂation, min 193 2
Time from presentation to ﬁrst balloon inﬂation, min 46 1
TIMI ﬂow grade 3 post-PCI 31 (94%
Values aremean SDor n (%). GroupA, remote ischemic periconditioningonly; GroupB, remote isch
infusion (control patients). *“Treatment” refers to the patients’ in-hospital MI management.
ACEI angiotensin-converting enzyme inhibitor; ARB angiotensin receptor blocker; CAD cPCI percutaneous coronary intervention; TIMI Thrombolysis In Myocardial Infarction.fﬁcacy measures. The measures used to assess the effi-
acy of the employed methods of reducing reperfusion
njury (RIPC and morphine infusion) were the achieve-
ent of full ST-segment resolution (primary end point),
nd the percent reduction of ST-segment deviation score
nd peak cardiac troponin I (TnI) levels attained during
ospitalization. The number of patients achieving full
T-segment resolution was the pre-specified primary
fficacy measure.
Resolution of ST-segment deviation after reperfusion has
een shown to be associated with better outcome after
TEMI (10,11). In the present study, ST-segment devia-
ion score was measured in 12-lead electrocardiograms,
alculated as the sum (in millimeters) of ST-segment
eviation (elevation or depression) at 80 ms after the
-point in all 12 leads. ST-segment deviation score was
easured at presentation and 30 min after PCI, by 2
hysicians blinded as to the patients’ data, and the mean value
f the 2 assessments was used. ST-segment resolution was
alculated as a percentage: ratio of the reduction in ST-
egment deviation score from presentation to half an hour after
CI over the ST-segment deviation score at presentation 
Group B
(n  33)
Group C
(n  30) p Value
63.9 11.2 61.2 10.9 NS
21 (64%) 18 (60%) NS
26 (79%) 20 (67%) NS
14 (42%) 12 (40%) NS
11 (33%) 9 (30%) NS
15 (45%) 13 (43%) NS
1.2 0.2 0.9 0.3 NS
4 (12%) 5 (17%) NS
4 (12%) 3 (10%) NS
8 (24%) 7 (23%) NS
0.48 0.06 0.44 0.05 NS
30 (98%) 30 (100%) NS
6 (18%) 4 (13%) NS
27 (82%) 28 (93%) NS
2 (6%) 1 (3%) NS
33 (100%) 30 (100%) NS
19.0 9.2 20.0 11.4 NS
198 28 192 35 NS
48 14 50 15 NS
30 (91%) 28 (93%) NS
ericonditioning andmorphine infusion; GroupC, no remote ischemic periconditioningormorphine
artery disease; CCB calcium channel blocker; MImyocardial infarction; NS not significant;ation
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5200% (i.e., [(ST-segment deviation at presentation 
T-segment deviation post-PCI)/ST-segment deviation at
resentation]  100%). Full ST-segment resolution was
efined as 80% or more reduction of ST-segment deviation
core.
Serum levels of TnI were measured using a commercially
vailable quantitative assay (Abbott Laboratories, Abbott Park,
Figure 2. Primary End Point Achievement per Group
Number of patients showing full resolution (80%) of ST-segment devia-
tion after percutaneous coronary intervention in each randomization group.
The difference was signiﬁcant for both Groups A and B, when compared to
the control group (p  0.045 in the Kruskal-Wallis test; p  0.015 in the
Jonckheere-Terpstra test). Slightly more patients in Group B than in Group
A achieved full resolution, but the difference between these 2 groups was
insigniﬁcant. Resolution of ST-segment changes: orange bars  incom-
plete resolution; green bars  full resolution.
Table 2. Peak TnI Levels and Percent Resolution of ST-Segment Changes i
n Mean SD SEM Lo
Peak TnI, ng/ml
Control group 30 255.5 194.5 35.5
Group A 33 166.0 160.8 28.0
Group B 33 103.3 76.5 13.3
Total 96 172.4 161.5 16.5
Resolution of ST-segment deviation, %
Control group 30 53.2 35.2 6.4
Group A 33 69.9 29.1 5.1
Group B 33 87.3 15.4 2.7
Total 96 70.6 30.6 3.1
GroupA, remote ischemic periconditioning only; Group B, remote ischemic periconditioning andmo
and p values refer to the differences between the 3 groups.SD standard deviation; SEM standard error of the mean; TnI troponin I.llinois), in blood samples collected using standard venipunc-
ure techniques on presentation and at regular intervals during
ospitalization. Blood was collected into pyrogen-free blood
ollection tubes and centrifuged, within 15 min from collec-
ion, using a centrifuge with an integrated refrigeration system
at 4oC, 3,000 g for 20 min). All serum samples thus obtained
ere analyzed in no more than 1 h.
tatistical analysis. Continuous variables are summarized as
ean value  SEM, unless otherwise indicated, and categor-
cal variables as counts and/or percentages. Comparisons of
ontinuous variables were made using analysis of variance,
pplying a general linear model, with post-hoc Bonferroni
orrection for multiple comparisons. In order to assess the
istributional assumptions for analysis of variance—normality
nd equal variance assumptions—the Kolmogorov-Smirnov
nd the Levene tests were used, respectively. For variables
hose distribution differed significantly from the normal
nd/or equal variance could not be assumed, nonparametric
nalysis was performed (Kruskal-Wallis and Jonckheere-
erpstra tests). Categorical variables were cross-tabulated and
he Fisher exact test was used for comparisons. Statistical
ignificance for all statistical tests was defined as p  0.05. All
tatistical analyses were performed with the SPSS version 15.0
tatistical software package (SPSS, Inc., Chicago, Illinois).
esults
tudy population and treatment. Ninety-six patients (59
en, age 62.7  11.1 years) were enrolled, fulfilling the
riteria outlined in the Methods section. Thirty-three pa-
ients were randomized to each treatment group (Group A:
IPC; Group B: RIPC and morphine infusion). A third
roup of control patients (Group C: no RIPC or morphine
nfusion) included 30 patients. All 3 groups were equivalent
3 Randomization Groups
5% Confidence
terval for Mean
ound Upper Bound Minimum Maximum F Statistic p Value
328.1 20 906 8.06 0.0006
223.0 25 801
130.4 24 421
205.1 20 906
66.3 0 90 12.06 0.00002
80.2 0 100
92.7 20 100
76.8 0 100
infusion; GroupC, no remote ischemic post-conditioning ormorphine infusion (controls). F statisticn the
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53s far as basic demographics and clinical parameters were
oncerned (Table 1). The time from symptom onset until
he first balloon inflation was 193  23 min in Group A,
98  28 min in Group B, and 192  35 min in Group C
p  NS). There were no significant differences in the time
rom presentation at the emergency room until first balloon
nflation between the 3 groups (Table 1). Inflation of the
rachial manometer cuff was used to start RIPC, which
as started on average 8  2 min before first balloon
nflation. ST-segment deviation score before PCI was
orrelated to peak TnI levels (Pearson correlation index:
.606; p  0.001).
fﬁcacy measures. When the resolution of ST-segment-
hanges was studied as a binary variable (with full resolution
eing considered as the primary end point of the study), there
as a significantly higher proportion of patients in Groups A
73%) and B (82%) who achieved full resolution half an hour
fter PCI than in the control group (53%) (p 0.045). Figure 2
llustrates the ascending number of patients with full resolution
f the ST-segment changes, from Group C (control) to Group
, to Group B.
As far as the resolution of ST-segment changes was
oncerned, as measured by the percent reduction of ST-
egment deviation score half an hour after PCI, and com-
ared with the pre-PCI ST-segment deviation score, there
as a marked difference in favor of patients in Group B
Table 2). More specifically, ST-segment deviation score
as reduced by 87.3  2.7% in Group B, compared with
9.9  5.1% in Group A and 53.2  6.4% in the control
roup (overall p  0.00002) (Fig. 3A). With the patients
ivided into tertiles according to the percent reduction of
T-segment deviation (ST-segment resolution tertiles), a
ignificant difference was observed in the distribution of
T-segment resolution tertiles in the 3 treatment groups
Fig. 4): most patients (61%) of Group B belonged to the
igher tertile of ST-segment resolution compared with 10%
f control patients (p  0.00018), whereas in Group A,
0%, 48.5%, and 21.5% of patients belonged to the lower,
iddle, and higher tertiles of ST-segment resolution.
The data for peak TnI levels and degree of ST-segment
eturn to baseline (expressed as percent reduction in ST-
egment deviation score) are summarized, per randomiza-
ion group, in Table 2.
The overall peak TnI level was 172.4 16.5 ng/ml. Peak
nI was lowest in patients who received both RIPC and
orphine (i.e., Group B), 103.3  13.3 ng/ml, in compar-
son to those who received only RIPC (i.e., Group A), 166.0
28.0 ng/ml, and the control group (i.e., Group C), 255.5
35.5 ng/ml (overall p  0.0006) (Fig. 3B). If the 2 active
reatment groups (Group A plus Group B) were aggregated
nd compared with the control group, peak TnI levels
ould be 134.7  15.9 ng/ml versus 255.5  35.5 ng/mlp  0.003). liscussion
he principal finding of the present study was the higher
roportion of STEMI patients achieving full resolution of
T-segment deviation 30 min after primary PCI, when
IPC was applied, both alone and in combination with
ntravenous infusion of an opioid receptor agonist, just
efore and at the onset or reperfusion. The addition of
orphine infusion to RIPC did not confer an increase in
he number of patients achieving full resolution (primary
easure of efficacy), but was associated with greater per-
entage of ST-segment resolution and lower peak TnI
Figure 3. Box Plot Graphs for ST-Segment Resolution Score and Peak TnI
Box plot graphs of peak troponin I (TnI) levels (A) and ST-segment resolu-
tion (B) in the 3 study groups. In both cases, remote ischemic pericondi-
tioning plus morphine fared signiﬁcantly better than no treatment. (The
whiskers indicate range, excluding outliers.)evels.
b
o
d
a
r
b
i
t
c
i
o
i
o
a
b
p
p
I
R
a
e
n
c
p
p
b
t
c
o
(
t
o
t
p
d
5
r
a
r
P
i
s
t
p
m
s
i
i
t
o
i
e
S
e
t
w
p
S
d
p
s
C
T
s
r
m
p
c
s
s
m
i
R
C
A
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 3 , N O . 1 , 2 0 1 0
J A N U A R Y 2 0 1 0 : 4 9 – 5 5
Rentoukas et al.
Remote Ischemic Periconditioning and Morphine
54The protective action of ischemic post-conditioning has
een known for some time, fueled by observations that gradual
r intermittent, rather than sudden, reperfusion reduces the
etrimental effects of ischemia-reperfusion injury (12,13). Ovize
nd colleagues have demonstrated that sequential cycles of
eperfusion and ischemia at the time of reperfusion (by serial
alloon inflations and deflations) not only leads to reduced
nfarct size at the immediate post-STEMI period (3), but also
o a long-term improvement in left ventricular function, when
ompared with control patients (4). The notion of remote
schemic pre- and post-conditioning refers to the phenomenon
f observed cardioprotection effected by short periods of
schemia applied not upon the myocardium itself, but on other
rgans or a limb (14–16).
Our results suggest a potentially important role of opioid
ction in ischemic post-conditioning. This is further supported
y recent observations indicating that the cardiomyocyte-
rotective action of ischemic pre-conditioning is blocked by
re-treatment with the opiate receptor blocker naloxone (17).
t should be duly noted, however, that the mechanisms of
IPC are not completely clear; it seems that humoral factors
re involved (17–19), which need to be active during the critical
arly stages of reperfusion to induce protection (20,21). Alter-
atively, a neurogenic pathway could be activated during
onditioning ischemia and induce protection in tissues (22).
One of the factors that have received attention as to their
ossible role in post-conditioning is mPTP. Under normal
hysiological conditions, the mitochondrial inner mem-
Figure 4. Distribution of Tertiles of ST-Segment Resolution per Group
Distribution of patients in tertiles of ST-segment resolution per randomiza-
tion group. Most patients falling in the upper tertile of ST-segment resolu-
tion belonged to Group B (p  0.001 for overall distribution difference
between groups). Tertile of ST-segment resolution: red bars  lower ter-
tile; yellow bars  middle tertile; green bars  higher tertile.rane is impermeable to almost all metabolites and ions, and
Ghe mPTP is in a closed conformation. Under some stress
onditions, the mPTP may open and allow the equilibration
f molecules smaller than approximately 1,500 Da
6,23,24). Ischemia-reperfusion combines several conditions
hat can trigger mPTP opening, including matrix Ca2
verload, overproduction of reactive oxygen species, deple-
ion of adenine nucleotides, and accumulation of inorganic
hosphates (6). It has also been shown that mPTP opening
oes not happen during ischemia, but occurs within the first
min of reflow following a 30-min ischemia in the isolated
at heart (25). The mPTP opening leads to destabilization
nd swelling of the mitochondria, with potentially lethal
esults for the cell, thus contributing to reperfusion injury.
ost-conditioning has been shown to inhibit mPTP open-
ng (7). Inhibition of mPTP opening has also been demon-
trated to be mediated by activation of delta-opioid recep-
ors, suggesting that opioid receptor activation-triggered
ost-conditioning may protect the heart by targeting the
PTP (8). It has also been demonstrated in a clinical
etting that cyclosporine, an immunosuppressant drug that
nhibits the opening of mPTP, attenuates lethal myocardial
njury that occurs at the time of reperfusion (9). It would,
hus, be a plausible assumption to make that a combination
f RIPC and inhibition of mPTP opening by morphine
nfusion, both initiated just before reperfusion onset, could
xert a cardioprotective effect.
tudy limitations. The present study did not assess clinical
nd points (cardiovascular events and/or deaths). As a result,
hese observations should be considered as supportive evidence,
hich may be used to promote further clinical study of the
otential cardioprotective role or RIPC and opioid agonists.
till, the parameters used as efficacy measures (ST-segment
eviation score and peak TnI levels) are known correlates of
ost–myocardial-infarction outcomes and represent legitimate
urrogate indicators of clinical prognosis.
onclusions
his single-center, parallel-group, randomized study demon-
trates a significant cardioprotective effect of RIPC during
eperfusion, in the setting of acute STEMI. The addition of
orphine infusion did not confer an improvement as far as the
rimary efficacy measure (full ST-segment resolution) was
oncerned, but was associated to greater ST-segment deviation
core reduction and lower peak TnI levels. These findings are
trongly suggestive of a potentially useful role of RIPC and
orphine administration for the prevention of reperfusion
njury in patients submitted to primary PCI.
eprint requests and correspondence: Dr. Georgios Giannopoulos,
ardiology Department and Cardiac Catheterization Laboratory,
thens General Hospital, M. Alexandrou 28, 15122 Marousi,
reece. E-mail: ggiann@med.uoa.gr.
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